Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04557709

Conditions

Hematopoietic and Lymphoid Cell Neoplasm

Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Medical Chart Review

Study Details

Brief summary:

This study investigates the major complication rate in cancer patients potentially eligible for a hospital at home program for management of neutropenic fever. "Hospital at Home" is a home care program that provides acute, inpatient care in a patient's home in place of a traditional hospital stay. Learning more about the characteristics of potentially eligible patients, including reasons for inpatient admission, rates of major complications, and situations or treatments that would be difficult to deliver in an at home setting may help to inform future program development.

Conditions

Hematopoietic and Lymphoid Cell Neoplasm

Malignant Solid Neoplasm

Study ID

NCT04557709

Start date

Jul 13, 2020

Status verified date

Aug, 2025

Completion date

Sep 30, 2025

Anticipated

Primary completion date

Sep 30, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Admitted to MD Anderson Cancer Center through the Emergency Center with a diagnosis of neutropenic fever between 1/1/2019 and 12/31/2019
  • Be at low risk for major complications as defined by a Multinational Association for Supportive Care in Cancer (MASCC) score < 21

Exclusion Criteria:

  • Reside in a nursing home
  • Homelessness
  • Hospice enrollment
  • A secondary reason for admission to the hospital or high risk clinical feature not captured in the MASCC score that places them at high risk for major complications in a hospital at home program

Study Design

Enrollment

126 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational (chart review)

Patients' medical charts are reviewed.

Interventions

Medical Chart Review

Review of medical charts

Primary outcome measure

  • Percentage of patients who experience major complications that require escalated care [ Time Frame: 1 month ]

Central Contacts and Locations

Central contacts

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Principal Investigator:

Tacara N. Soones

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Aug 15, 2025

Last verified

Aug, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2025-08-15.